Takeda Pharmaceutical Company Limited researches, develops, manufactures, markets and out-licenses pharmaceutical products in gastroenterology, rare diseases, plasma-derived therapies, oncology, vaccines and neuroscience, with brands including Entyvio, Takhzyro, Adcetris, Vyvanse and QDENGA. It operates in Japan, the United States, Europe, Canada, Latin America, China, Asia, Russia/CIS, the Middle East, Oceania and Africa.